Global Chronic Obstructive Pulmonary Disorder (COPD) Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2017-2028

2.1.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Chronic Obstructive Pulmonary Disorder (COPD) Segment by Type

2.2.1 Short-Acting Bronchodilators

2.2.2 Corticosteroids

2.2.3 Methylxanthines

2.2.4 Long-Acting Bronchodilators

2.2.5 Phosphodiesterase-4 Inhibitors

2.2.6 Others

2.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type

2.3.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

2.4 Chronic Obstructive Pulmonary Disorder (COPD) Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application

2.5.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

3 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Player

3.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Players

3.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Players (2020-2022)

3.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Players (2020-2022)

3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Chronic Obstructive Pulmonary Disorder (COPD) by Regions

4.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions (2017-2022)

4.2 Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth (2017-2022)

4.3 APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth (2017-2022)

4.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth (2017-2022)

4.5 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth (2017-2022)

5 Americas

5.1 Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022)

5.2 Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)

5.3 Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022)

6.2 APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)

6.3 APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) by Country (2017-2022)

7.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)

7.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) by Region (2017-2022)

8.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022)

8.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Regions (2023-2028)

10.1.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Regions (2023-2028)

10.1.2 Americas Chronic Obstructive Pulmonary Disorder (COPD) Forecast

10.1.3 APAC Chronic Obstructive Pulmonary Disorder (COPD) Forecast

10.1.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Forecast

10.1.5 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Forecast

10.2 Americas Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Country (2023-2028)

10.2.1 United States Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.2.2 Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.2.3 Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.2.4 Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3 APAC Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Region (2023-2028)

10.3.1 China Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3.2 Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3.3 Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3.4 Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3.5 India Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.3.6 Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Country (2023-2028)

10.4.1 Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.4.2 France Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.4.3 UK Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.4.4 Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.4.5 Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.5 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Region (2023-2028)

10.5.1 Egypt Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.5.2 South Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.5.3 Israel Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.5.4 Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.5.5 GCC Countries Chronic Obstructive Pulmonary Disorder (COPD) Market Forecast

10.6 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Type (2023-2028)

10.7 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GSK

11.1.1 GSK Company Information

11.1.2 GSK Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.1.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GSK Main Business Overview

11.1.5 GSK Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Merck

11.3.1 Merck Company Information

11.3.2 Merck Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.3.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck Main Business Overview

11.3.5 Merck Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.4.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 AstraZeneca

11.5.1 AstraZeneca Company Information

11.5.2 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 AstraZeneca Main Business Overview

11.5.5 AstraZeneca Latest Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Information

11.6.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Boehringer Ingelheim Main Business Overview

11.6.5 Boehringer Ingelheim Latest Developments

11.7 Teva Pharmaceuticals

11.7.1 Teva Pharmaceuticals Company Information

11.7.2 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Teva Pharmaceuticals Main Business Overview

11.7.5 Teva Pharmaceuticals Latest Developments

11.8 Ario Pharma

11.8.1 Ario Pharma Company Information

11.8.2 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ario Pharma Main Business Overview

11.8.5 Ario Pharma Latest Developments

11.9 Roche

11.9.1 Roche Company Information

11.9.2 Roche Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.9.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Roche Main Business Overview

11.9.5 Roche Latest Developments

11.10 Ache

11.10.1 Ache Company Information

11.10.2 Ache Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.10.3 Ache Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Ache Main Business Overview

11.10.5 Ache Latest Developments

11.11 Almirall

11.11.1 Almirall Company Information

11.11.2 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.11.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Almirall Main Business Overview

11.11.5 Almirall Latest Developments

11.12 Aquinox Pharmaceuticals

11.12.1 Aquinox Pharmaceuticals Company Information

11.12.2 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Aquinox Pharmaceuticals Main Business Overview

11.12.5 Aquinox Pharmaceuticals Latest Developments

11.13 Asmacure

11.13.1 Asmacure Company Information

11.13.2 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Asmacure Main Business Overview

11.13.5 Asmacure Latest Developments

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Information

11.14.2 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Astellas Pharma Main Business Overview

11.14.5 Astellas Pharma Latest Developments

12 Research Findings and Conclusion

Table 1. Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Short-Acting Bronchodilators

Table 3. Major Players of Corticosteroids

Table 4. Major Players of Methylxanthines

Table 5. Major Players of Long-Acting Bronchodilators

Table 6. Major Players of Phosphodiesterase-4 Inhibitors

Table 7. Major Players of Others

Table 8. Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

Table 11. Chronic Obstructive Pulmonary Disorder (COPD) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

Table 14. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Player (2020-2022)

Table 16. Chronic Obstructive Pulmonary Disorder (COPD) Key Players Head office and Products Offered

Table 17. Chronic Obstructive Pulmonary Disorder (COPD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Regions (2017-2022)

Table 22. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Country (2017-2022)

Table 24. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

Table 26. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

Table 28. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Region (2017-2022)

Table 30. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

Table 32. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

Table 34. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Country (2017-2022)

Table 36. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

Table 38. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Chronic Obstructive Pulmonary Disorder (COPD)

Table 47. Key Market Challenges & Risks of Chronic Obstructive Pulmonary Disorder (COPD)

Table 48. Key Industry Trends of Chronic Obstructive Pulmonary Disorder (COPD)

Table 49. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share Forecast by Application (2023-2028)

Table 55. GSK Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 56. GSK Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 57. GSK Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. GSK Main Business

Table 59. GSK Latest Developments

Table 60. Pfizer Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 61. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 62. Pfizer Main Business

Table 63. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Pfizer Latest Developments

Table 65. Merck Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 66. Merck Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 67. Merck Main Business

Table 68. Merck Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Merck Latest Developments

Table 70. Novartis Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 71. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 72. Novartis Main Business

Table 73. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Novartis Latest Developments

Table 75. AstraZeneca Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 76. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 77. AstraZeneca Main Business

Table 78. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. AstraZeneca Latest Developments

Table 80. Boehringer Ingelheim Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 81. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 82. Boehringer Ingelheim Main Business

Table 83. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Boehringer Ingelheim Latest Developments

Table 85. Teva Pharmaceuticals Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 86. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 87. Teva Pharmaceuticals Main Business

Table 88. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Teva Pharmaceuticals Latest Developments

Table 90. Ario Pharma Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 91. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 92. Ario Pharma Main Business

Table 93. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Ario Pharma Latest Developments

Table 95. Roche Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 96. Roche Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 97. Roche Main Business

Table 98. Roche Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Roche Latest Developments

Table 100. Ache Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 101. Ache Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 102. Ache Main Business

Table 103. Ache Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Ache Latest Developments

Table 105. Almirall Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 106. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 107. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Almirall Main Business

Table 109. Almirall Latest Developments

Table 110. Aquinox Pharmaceuticals Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 111. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 112. Aquinox Pharmaceuticals Main Business

Table 113. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Aquinox Pharmaceuticals Latest Developments

Table 115. Asmacure Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 116. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 117. Asmacure Main Business

Table 118. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Asmacure Latest Developments

Table 120. Astellas Pharma Details, Company Type, Chronic Obstructive Pulmonary Disorder (COPD) Area Served and Its Competitors

Table 121. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offered

Table 122. Astellas Pharma Main Business

Table 123. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Astellas Pharma Latest Developments

List of Figures

Figure 1. Chronic Obstructive Pulmonary Disorder (COPD) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type in 2021

Figure 7. Chronic Obstructive Pulmonary Disorder (COPD) in Hospital

Figure 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Chronic Obstructive Pulmonary Disorder (COPD) in Clinic

Figure 10. Global Chronic Obstructive Pulmonary Disorder (COPD) Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application in 2021

Figure 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Player in 2021

Figure 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2017-2022 ($ Millions)

Figure 15. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2017-2022 ($ Millions)

Figure 16. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2017-2022 ($ Millions)

Figure 18. Americas Chronic Obstructive Pulmonary Disorder (COPD) Value Market Share by Country in 2021

Figure 19. Americas Chronic Obstructive Pulmonary Disorder (COPD) Consumption Market Share by Type in 2021

Figure 20. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application in 2021

Figure 21. United States Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Region in 2021

Figure 26. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application in 2021

Figure 27. China Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Country in 2021

Figure 34. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type in 2021

Figure 35. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application in 2021

Figure 36. Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Market Share by Application in 2021

Figure 44. Egypt Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 50. APAC Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 51. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 53. United States Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 54. Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 57. China Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 58. Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 59. Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 61. India Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 62. Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 63. Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 64. France Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 65. UK Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 66. Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 67. Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 68. Spain Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 71. Israel Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Chronic Obstructive Pulmonary Disorder (COPD) Market Size 2023-2028 ($ Millions)